Want to join the conversation?
$MDT's 2Q16 non-GAAP diluted EPS was $1.03. This is growing at 11% on a comparable constant currency basis and reflects a leverage of 480 BP. Revenue growth is the result of execution on three strategies; health innovation, globalization and economic value. $MDT's therapies growth sector accounted for nearly three quarters of total company growth.
Looking forward for $STT’s 2017 first quarter earnings results. Is it possible for them to outperform their estimates?
$HAL has cautioned that its 1Q profit is likely to miss projections. I’m expecting EPS to be in low single digits.!
$GOOG is losing more advertisers after the boycotts over extremist ads. Future is not so bright for Google in the advertising sector..!